The Customer
A global pharmaceutical leader in Neurology, managing over 20 brands across 100+ countries.
Challenges
MLR review inefficiencies were slowing down content readiness and market responsiveness.
- Changes in content consumption trends led to a 3X increase in materials needing MLR approval.
- Existing MLR capacity couldn’t keep up, causing delays and frequent non-compliance with turnaround SLAs.
- Slower content approvals meant missed opportunities in brand promotion and HCP engagement.
- Without automation or standardization, 20% of assets had errors post-production, requiring rework and risking compliance.
The Solution
Comprehensive process diagnostics:
Via documentation review, interviews and benchmarking against best-in-class industry practices.Gap analysis:
Uncovered 20+ gaps identified across material quality, review efficiency, people, and scalability.Strategic Roadmap:
Delivered 15+ actionable recommendations, balancing quick wins with long-term improvements.
Outcomes
- Faster time to market leading to reduction in business opportunity cost
- Reduction in review cycles due to improved quality of assets
- Elimination of errors in postproduction files
- Reduction in review costs due to improved productivity and leaner content review